MediWound Ltd.
MDWD- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- SEC CIK
- 0001593984
In the last 90 days, MediWound Ltd. insiders filed 1 open-market purchase and 2 sales; 78 institutions reported holding it in 13F filings for Q2 2026, worth $85.5M in total; ARK Invest is the only superinvestor holding it.
Q2 2022 vs. Q1 2022
How the institutions holding MediWound Ltd. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 28 | 20 | −8 |
| Shares | 2.77M | 3.06M | +292.4K (+10.6%) |
| Value | $5.50M | $5.63M | +$132.9K (+2.4%) |
New holders (1)
Institutions that held MediWound Ltd. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Tower Research Capital LLC (TRC) | 3,712 | $7.00K | 0.00% |
Sold out (9)
Institutions that held MediWound Ltd. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Migdal Insurance & Financial Holdings Ltd. | 216,946 | $432.0K |
| Bokf, NA | 53,559 | $107.0K |
| Warberg Asset Management LLC | 21,873 | $44.0K |
| JPMorgan Chase & Co | 2,969 | $6.00K |
| Koshinski Asset Management, Inc. | 2,275 | $4.53K |
| ARK Investment Management LLCSuperinvestorARK Invest | 2,024 | $4.00K |
| Barclays PLC | 1 | $0 |
| Simplex Trading, LLC | 452 | $0 |
| FinTrust Capital Advisors, LLC | 100 | $0 |